8-K: VSee Health Sets 2025 Annual Meeting & Proposal Deadlines
Annual Meeting Announcement
VSee Health, Inc. announced the date for its 2025 annual stockholders meeting and key deadlines for stockholder proposals.
Summary
- The Board of Directors of VSee Health, Inc. established December 15, 2025, as the date for the Company's 2025 Annual Meeting of Stockholders.
- November 20, 2025, has been set as the record date for determining stockholders eligible to receive notice and vote at the 2025 Annual Meeting.
- The deadline for stockholder proposals to be presented at the 2025 Annual Meeting, including those for inclusion in proxy materials under Rule 14a-8, is the close of business on November 7, 2025.
- This November 7, 2025, deadline also applies to timely notice for exercising discretionary voting authority with respect to proxies under Rule 14a-4(c) of the Exchange Act.
- Stockholders intending to solicit proxies for director nominees other than the Company's nominees must provide notice by November 7, 2025, as required by Rule 14a-19 under the Exchange Act.
- All proposals must be addressed to the Secretary and Chief Financial Officer at VSee Health, Inc., 980 N. Federal Highway, Suite 304, Boca Raton, Florida 33432.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine administrative announcement regarding the annual meeting and stockholder proposal deadlines, with no direct financial or operational implications.
Future Outlook
The Company will publish additional details regarding the exact time, location, and matters to be voted on at the 2025 Annual Meeting in its proxy statement.
Industry Context
This is a standard administrative announcement common across publicly traded companies, ensuring compliance with SEC regulations and corporate governance best practices regarding annual stockholder meetings.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Annual Meeting Scheduling | The Board of Directors established the date for the 2025 annual meeting of stockholders and set the record date and deadlines for stockholder proposals. | 2025-10-22 | Ensures compliance with corporate governance requirements and provides clarity for shareholder participation in the annual meeting and proposal submission process. |
Stakeholder Impact
- Shareholders: Provides essential information regarding the upcoming annual meeting, including the meeting date, record date, and deadlines for submitting proposals or nominating directors, enabling their participation in corporate governance.
Next Steps
- Publish additional details regarding the exact time, location, and matters to be voted on at the 2025 Annual Meeting in the Company's proxy statement.
Key Dates
| Date | Description |
|---|---|
| 2025-10-22 | Date of earliest event reported; Board of Directors established the 2025 Annual Meeting date and record date. |
| 2025-10-28 | Date the Current Report on Form 8-K was signed. |
| 2025-11-07 | Deadline for stockholder proposals, including those for inclusion in proxy materials (Rule 14a-8), for discretionary voting authority (Rule 14a-4(c)), for business properly brought before the meeting by a stockholder, and for universal proxy rules (Rule 14a-19). |
| 2025-11-20 | Record date for determining stockholders eligible to receive notice of and vote at the 2025 Annual Meeting. |
| 2025-12-15 | Date of the Company's 2025 Annual Meeting of Stockholders. |
Recommendation
holdThis 8-K filing is a routine administrative announcement regarding the scheduling of the annual meeting and associated deadlines for stockholder proposals. It does not contain any financial performance updates, strategic shifts, or other material information that would warrant a change in investment recommendation. Investors should maintain their current position based on existing fundamental analysis.
Keywords
VSee Health, Annual Meeting, Stockholder Meeting, Proxy Statement, Corporate Governance, Shareholder Proposals, 8-K Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.